A Study of BGM0504 in Participants With Obesity

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects

NCT06714955 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

NCT07166081 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

NCT06643728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

NCT05024032 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

NCT06737042 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Tirzepatide for Weight Management

NCT06918405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects

NCT06728124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

NCT05997576 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT06047548 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects

NCT06974487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

A Study of TG103 Injection in the Management of Non-diabetic Overweight or Obesity

NCT06226090 ·Status: COMPLETED ·Phase: PHASE2

A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

NCT06901349 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

NCT06839664 ·Status: RECRUITING ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity

NCT06373146 ·Status: COMPLETED ·Phase: PHASE2

Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects

NCT07150975 ·Status: RECRUITING ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)

NCT05963022 ·Status: COMPLETED ·Phase: PHASE3

A Study of IBI362 9 mg in Chinese Adults With Obesity

NCT06164873 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

NCT04184622 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

NCT06214741 ·Status: COMPLETED ·Phase: PHASE3

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

NCT07247084 ·Status: RECRUITING ·Phase: PHASE4

A Study of GZR18 Injection in Chinese Obese/Overweight Patients

NCT06256536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)

NCT07099742 ·Status: NOT_YET_RECRUITING

A Study of GZR18 Injection in Obese/Overweight Patients

NCT06256562 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

NCT05616013 ·Status: COMPLETED ·Phase: PHASE2